---
title: "Enterprises Step Up Deployment, Commercialization of Brain-Computer Interfaces Accelerates"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282256475.md"
description: "As one of the industries of the future, Brain-Computer Interface (BCI) has become a core market focus at the 93rd China International Medical Equipment Fair (CMEF), attracting widespread attention. Companies such as Xiangyu Medical, VISHEE, and Neuracle showcased related products and technological innovations, driving industry development. Industry insiders believe that China's brain-computer interface industry is accelerating clinical translation, and the commercialization prospects in the medical field are worth looking forward to"
datetime: "2026-04-09T22:32:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282256475.md)
  - [en](https://longbridge.com/en/news/282256475.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282256475.md)
generator: "portal-rs"
---

# Enterprises Step Up Deployment, Commercialization of Brain-Computer Interfaces Accelerates

As one of the future industries forward-lookingly planned in the outline of the 15th Five-Year Plan, Brain-Computer Interface (BCI) has become a core market focus area at the 93rd China International Medical Equipment Fair (CMEF), attracting extensive attention from both inside and outside the industry. During the exhibition, several key industry enterprises, including Xiangyu Medical, VISHEE, and Neuracle, showcased their respective products, centrally displaying their technological accumulation and innovative achievements in the brain-computer interface field, injecting new momentum into industry development. Industry insiders believe that China's brain-computer interface industry is entering a period of accelerated clinical translation. As more products gradually receive approval, the commercialization prospects of brain-computer interface technology landing in the medical field are worth looking forward to. (China Securities Journal)

### Related Stocks

- [688626.CN](https://longbridge.com/en/quote/688626.CN.md)
- [688580.CN](https://longbridge.com/en/quote/688580.CN.md)

## Related News & Research

- [Neko Health to Help Screen Candidates for Neuralink Trial](https://longbridge.com/en/news/296690963.md)
- [Asker Healthcare Group buys Baltic medtech distributor Ambercell Solutions](https://longbridge.com/en/news/296306272.md)
- [11:19 ETEon Appoints Matthew Lungren, MD, MPH, to Board of Directors](https://longbridge.com/en/news/296375443.md)
- [Echo IQ Issues New Shares Following Option Exercise](https://longbridge.com/en/news/296588483.md)
- [09:30 ETFirst Mold Returns to Meximold 2026: Enhanced Large‑Part Capacity for North America](https://longbridge.com/en/news/296624448.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**